Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer.
Saved in:
| Title: | Genomic Activation of PPARG Reveals a Candidate Therapeutic Axis in Bladder Cancer. |
|---|---|
| Authors: | Goldstein JT; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Berger AC; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Shih J; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Duke FF; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Furst L; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts., Kwiatkowski DJ; Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Cherniack AD; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts., Meyerson M; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts. matthew_meyerson@dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Cancer Genome Discovery, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Harvard Medical School, Boston, Massachusetts., Strathdee CA; The Broad Institute of MIT and Harvard, Cambridge, Massachusetts. |
| Source: | Cancer research [Cancer Res] 2017 Dec 15; Vol. 77 (24), pp. 6987-6998. Date of Electronic Publication: 2017 Sep 18. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 2984705R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1538-7445 (Electronic) Linking ISSN: 00085472 NLM ISO Abbreviation: Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
